10x Genomics, Inc. (TXG) Operating margin 2017–2025
10x Genomics, Inc. (TXG) operating margin by fiscal year — reported operating income divided by reported revenue.
-9.5%FY2025 · since FY2017: -25.8% → -9.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -9.5% | +22.4 pp |
| FY2024 | -31.9% | +11.0 pp |
| FY2023 | -42.9% | -10.4 pp |
| FY2022 | -32.5% | -21.9 pp |
| FY2021 | -10.7% | +168.1 pp |
| FY2020 | -178.7% | -166.3 pp |
| FY2019 | -12.4% | +63.3 pp |
| FY2018 | -75.7% | -49.9 pp |
| FY2017 | -25.8% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice